FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081083670> ?p ?o ?g. }

• W2081083670 endingPage "807.e9" @default.
• W2081083670 startingPage "800" @default.
• W2081083670 abstract "IL-13 is a key T(H)2 cytokine that is implicated in allergic responses.We evaluated the effects of an anti-IL-13-blocking antibody compared with placebo on repeated nasal allergen challenge responses in hay fever patients out of season.We performed a parallel group double-blind study of anti-IL-13 (single dose, 6 mg/kg intravenously, n = 16) and placebo (n = 15), with an additional open label group given a topical nasal corticosteroid (n = 5). Subjects received intranasal timothy grass pollen (Phleum pratense P5 allergen), and serial samples of nasal mucosal lining fluid were taken by using synthetic absorptive matrix and by nasal lavage.Administration of anti-IL-13 on day 1 resulted in a significant decrease in IL-13 levels in synthetic absorptive matrix eluates compared with placebo (area under the curve 0-8 hours, change from baseline) during the late phase after nasal allergen challenge on day 5 (P < .05) and day 7 (P < .01). There were no apparent effects of anti-IL-13 treatment on nasal lavage eosinophil numbers or total nasal symptom scores versus placebo. However, in a subgroup with high late-phase IL-13 levels at screening, there was a trend for a decrease in total nasal symptom scores after nasal allergen challenge on day 5, when compared with subjects with low IL-13 levels (P < .10). Nasal fluticasone caused suppression of IL-13 (P < .05 on day 5) as well as IL-5 (P < .01 on day 5) levels in the late phase compared with placebo.Anti-IL-13 had specific pharmacodynamic action in this nasal allergen challenge model, causing profound inhibition of nasal lining fluid IL-13 responses. In addition, there was a possible effect of anti-IL-13 treatment on total nasal symptom scores in a subgroup with high late-phase nasal IL-13 levels at screening." @default.
• W2081083670 created "2016-06-24" @default.
• W2081083670 creator A5003397190 @default.
• W2081083670 creator A5021191544 @default.
• W2081083670 creator A5030258071 @default.
• W2081083670 creator A5034802483 @default.
• W2081083670 creator A5035864541 @default.
• W2081083670 creator A5043208437 @default.
• W2081083670 creator A5051876182 @default.
• W2081083670 creator A5054354811 @default.
• W2081083670 creator A5056795918 @default.
• W2081083670 creator A5059041416 @default.
• W2081083670 creator A5063798906 @default.
• W2081083670 creator A5075381133 @default.
• W2081083670 creator A5081300602 @default.
• W2081083670 date "2011-10-01" @default.
• W2081083670 modified "2023-10-11" @default.
• W2081083670 title "The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge" @default.
• W2081083670 cites W1846706131 @default.
• W2081083670 cites W1970648068 @default.
• W2081083670 cites W1984708466 @default.
• W2081083670 cites W1988758075 @default.
• W2081083670 cites W1994585625 @default.
• W2081083670 cites W2006744847 @default.
• W2081083670 cites W2043046650 @default.
• W2081083670 cites W2047031939 @default.
• W2081083670 cites W2052628757 @default.
• W2081083670 cites W2062918919 @default.
• W2081083670 cites W2065997245 @default.
• W2081083670 cites W2067360235 @default.
• W2081083670 cites W2080331925 @default.
• W2081083670 cites W2095606387 @default.
• W2081083670 cites W2100990833 @default.
• W2081083670 cites W2107207387 @default.
• W2081083670 cites W2112580075 @default.
• W2081083670 cites W2124566107 @default.
• W2081083670 cites W2125805192 @default.
• W2081083670 cites W2142587628 @default.
• W2081083670 cites W2157471713 @default.
• W2081083670 cites W2157566717 @default.
• W2081083670 cites W2164513774 @default.
• W2081083670 cites W2168421693 @default.
• W2081083670 cites W2170307869 @default.
• W2081083670 doi "https://doi.org/10.1016/j.jaci.2011.05.013" @default.
• W2081083670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21719078" @default.
• W2081083670 hasPublicationYear "2011" @default.
• W2081083670 type Work @default.
• W2081083670 sameAs 2081083670 @default.
• W2081083670 citedByCount "54" @default.
• W2081083670 countsByYear W20810836702012 @default.
• W2081083670 countsByYear W20810836702013 @default.
• W2081083670 countsByYear W20810836702014 @default.
• W2081083670 countsByYear W20810836702015 @default.
• W2081083670 countsByYear W20810836702016 @default.
• W2081083670 countsByYear W20810836702017 @default.
• W2081083670 countsByYear W20810836702018 @default.
• W2081083670 countsByYear W20810836702019 @default.
• W2081083670 countsByYear W20810836702020 @default.
• W2081083670 countsByYear W20810836702021 @default.
• W2081083670 countsByYear W20810836702022 @default.
• W2081083670 countsByYear W20810836702023 @default.
• W2081083670 crossrefType "journal-article" @default.
• W2081083670 hasAuthorship W2081083670A5003397190 @default.
• W2081083670 hasAuthorship W2081083670A5021191544 @default.
• W2081083670 hasAuthorship W2081083670A5030258071 @default.
• W2081083670 hasAuthorship W2081083670A5034802483 @default.
• W2081083670 hasAuthorship W2081083670A5035864541 @default.
• W2081083670 hasAuthorship W2081083670A5043208437 @default.
• W2081083670 hasAuthorship W2081083670A5051876182 @default.
• W2081083670 hasAuthorship W2081083670A5054354811 @default.
• W2081083670 hasAuthorship W2081083670A5056795918 @default.
• W2081083670 hasAuthorship W2081083670A5059041416 @default.
• W2081083670 hasAuthorship W2081083670A5063798906 @default.
• W2081083670 hasAuthorship W2081083670A5075381133 @default.
• W2081083670 hasAuthorship W2081083670A5081300602 @default.
• W2081083670 hasConcept C126322002 @default.
• W2081083670 hasConcept C142724271 @default.
• W2081083670 hasConcept C181901479 @default.
• W2081083670 hasConcept C203014093 @default.
• W2081083670 hasConcept C204787440 @default.
• W2081083670 hasConcept C207480886 @default.
• W2081083670 hasConcept C27081682 @default.
• W2081083670 hasConcept C2776042228 @default.
• W2081083670 hasConcept C2777037409 @default.
• W2081083670 hasConcept C2777917907 @default.
• W2081083670 hasConcept C2778690821 @default.
• W2081083670 hasConcept C2780510475 @default.
• W2081083670 hasConcept C2780973058 @default.
• W2081083670 hasConcept C2909814679 @default.
• W2081083670 hasConcept C59377437 @default.
• W2081083670 hasConcept C71924100 @default.
• W2081083670 hasConcept C74172505 @default.
• W2081083670 hasConcept C85663871 @default.
• W2081083670 hasConcept C90924648 @default.
• W2081083670 hasConceptScore W2081083670C126322002 @default.
• W2081083670 hasConceptScore W2081083670C142724271 @default.
• W2081083670 hasConceptScore W2081083670C181901479 @default.
• W2081083670 hasConceptScore W2081083670C203014093 @default.

• next